SAHMRI Precision Cancer Medicine Theme International Women’s Day Seminar

Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

Description

Eadie LN, Page, EC, Schutz CE, Rehn JA, White DL
Asciminib is a novel targeted inhibitor of the NUP214::ABL1 fusion gene in B-cell and T-cell acute lymphoblastic leukaemia
Oral Presentation, invited speaker
Adelaide, South Australia
Period8 Mar 2023
Event titleSAHMRI Precision Cancer Medicine Theme Seminar Series
Event typeSeminar
LocationAdelaide, Australia, South AustraliaShow on map
Degree of RecognitionLocal